CDKN2A and lung carcinoma: As early as 2005, Schmiemann V et al. discovered the abnormal methylation level of APC, p16 (INK4a), and RASSF1A genes in lung cancer patients, and proposed using methylation biomarkers for early diagnosis of lung cancer [16].